Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice ; volume:12 ; number:1 ; day:17 ; month:6 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (17.6.2022), 1-13, 12.2022
- Creator
-
Al-Griw, Mohamed A.
Alshibani, Zaynab Osama
Alghazeer, Rabia
Elhensheri, Mohamed
Tabagh, Refaat. M.
Eskandrani, Areej A.
Alansari, Wafa S.
Habibulla, Mahmoud M.
Shamlan, Ghalia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-12937-4
- URN
-
urn:nbn:de:101:1-2022081623242046138287
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Al-Griw, Mohamed A.
- Alshibani, Zaynab Osama
- Alghazeer, Rabia
- Elhensheri, Mohamed
- Tabagh, Refaat. M.
- Eskandrani, Areej A.
- Alansari, Wafa S.
- Habibulla, Mahmoud M.
- Shamlan, Ghalia
- SpringerLink (Online service)
Other Objects (12)
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
Histone deacetylase 6 in cancer
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
Histone deacetylase 6 in cancer
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
Histone deacetylase 6 in cancer
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus